SU555850A3 - Способ получени производных хиназолина - Google Patents
Способ получени производных хиназолинаInfo
- Publication number
- SU555850A3 SU555850A3 SU2095549A SU2095549A SU555850A3 SU 555850 A3 SU555850 A3 SU 555850A3 SU 2095549 A SU2095549 A SU 2095549A SU 2095549 A SU2095549 A SU 2095549A SU 555850 A3 SU555850 A3 SU 555850A3
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- quinazoline derivatives
- tetrahydro
- obtaining
- general formula
- obtaining quinazoline
- Prior art date
Links
- 125000002294 quinazolinyl group Chemical class N1=C(N=CC2=CC=CC=C12)* 0.000 title 1
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- -1 2- isoindolinyl Chemical group 0.000 description 5
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- OCUCCJIRFHNWBP-IYEMJOQQSA-L Copper gluconate Chemical class [Cu+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OCUCCJIRFHNWBP-IYEMJOQQSA-L 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- OHLUUHNLEMFGTQ-UHFFFAOYSA-N N-methylacetamide Chemical compound CNC(C)=O OHLUUHNLEMFGTQ-UHFFFAOYSA-N 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 125000005055 alkyl alkoxy group Chemical group 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-M bisulphate group Chemical group S([O-])(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229940113088 dimethylacetamide Drugs 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-L fumarate(2-) Chemical class [O-]C(=O)\C=C\C([O-])=O VZCYOOQTPOCHFL-OWOJBTEDSA-L 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 150000002688 maleic acid derivatives Chemical class 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 150000003891 oxalate salts Chemical class 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical compound N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 150000003892 tartrate salts Chemical class 0.000 description 1
- ILWRPSCZWQJDMK-UHFFFAOYSA-N triethylazanium;chloride Chemical compound Cl.CCN(CC)CC ILWRPSCZWQJDMK-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB4199272A GB1383409A (en) | 1972-09-09 | 1972-09-09 | Derivatives of 2-amino- and 4-amino-quinazoline and pharmaceutical compositions containing them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU555850A3 true SU555850A3 (ru) | 1977-04-25 |
Family
ID=10422335
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU2095549A SU555850A3 (ru) | 1972-09-09 | 1975-01-08 | Способ получени производных хиназолина |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US3960861A (cg-RX-API-DMAC7.html) |
| JP (1) | JPS4985078A (cg-RX-API-DMAC7.html) |
| AR (1) | AR203373A1 (cg-RX-API-DMAC7.html) |
| AT (1) | AT330785B (cg-RX-API-DMAC7.html) |
| BE (1) | BE804558A (cg-RX-API-DMAC7.html) |
| CA (1) | CA995673A (cg-RX-API-DMAC7.html) |
| DE (2) | DE2366106C2 (cg-RX-API-DMAC7.html) |
| DK (1) | DK131725C (cg-RX-API-DMAC7.html) |
| ES (1) | ES418612A1 (cg-RX-API-DMAC7.html) |
| FR (1) | FR2198751B1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB1383409A (cg-RX-API-DMAC7.html) |
| IE (1) | IE38318B1 (cg-RX-API-DMAC7.html) |
| IN (2) | IN139088B (cg-RX-API-DMAC7.html) |
| LU (1) | LU68373A1 (cg-RX-API-DMAC7.html) |
| NL (1) | NL161152C (cg-RX-API-DMAC7.html) |
| SU (1) | SU555850A3 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA735660B (cg-RX-API-DMAC7.html) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2296757C2 (ru) * | 2002-07-05 | 2007-04-10 | Ф.Хоффманн-Ля Рош Аг | Производные хиназолина |
| RU2664643C2 (ru) * | 2014-01-24 | 2018-08-21 | Ф. Хоффманн-Ля Рош Аг | Способ получения n-[(3-аминооксетан-3-ил)метил]-2-(1,1-диоксо-3,5-дигидро-1,4-бензотиазепин-4ил)-6-метил-хиназолин-4-амина |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4044136A (en) * | 1972-09-09 | 1977-08-23 | Pfizer Inc. | Aminoquinazoline therapeutic agents |
| GR79603B (cg-RX-API-DMAC7.html) * | 1982-07-24 | 1984-10-31 | Pfizer | |
| US4555569A (en) * | 1983-06-28 | 1985-11-26 | Ciba-Geigy Corporation | Chromogenic quinazolines |
| US5444062A (en) * | 1990-11-06 | 1995-08-22 | Pfizer Inc. | Quinazolines derivatives for enhancing antitumor activity |
| KR0144833B1 (ko) * | 1992-12-28 | 1998-07-15 | 김태훈 | 신규의 퀴나졸린 유도체 및 그의 제조방법 |
| DE4338396A1 (de) * | 1993-11-10 | 1995-05-11 | Basf Ag | N-Substituierte Azabicycloalkan-Derivate, ihre Herstellung und Verwendung |
| IT1286302B1 (it) * | 1996-04-10 | 1998-07-08 | Rotta Research Lab | Chinazoline-4-amino-2-(piperidino-1-il-4-sostituite) ad attivita' anti-ipertensiva, procedimento per la loro preparazione e loro uso |
| IN188411B (cg-RX-API-DMAC7.html) | 1997-03-27 | 2002-09-21 | Yuhan Corp | |
| KR100272471B1 (ko) | 1998-11-17 | 2000-11-15 | 김선진 | 신규의 피리미딘 유도체 및 그의 제조방법 |
| US6900220B2 (en) | 2001-01-02 | 2005-05-31 | Syntex (U.S.A.) Llc | Quinazolone derivatives as alpha 1A/B adrenergic receptor antagonists |
| DE602007011773D1 (de) * | 2006-08-04 | 2011-02-17 | Merz Pharma Gmbh & Co Kgaa | Substituierte pyrazolopyrimidine, ein verfahren zu ihrer herstellung und ihre verwendung als medizin |
| US8871756B2 (en) * | 2011-08-11 | 2014-10-28 | Hoffmann-La Roche Inc. | Compounds for the treatment and prophylaxis of Respiratory Syncytial Virus disease |
| WO2015018797A2 (en) * | 2013-08-05 | 2015-02-12 | Haplogen Gmbh | Antiviral compounds |
| CN107635999B (zh) | 2015-05-20 | 2020-09-25 | 豪夫迈·罗氏有限公司 | 用于治疗脊髓性肌萎缩的化合物 |
| WO2017009316A1 (en) | 2015-07-16 | 2017-01-19 | F. Hoffmann-La Roche Ag | Crystalline forms of n-[(3-amino-3-oxetanyl)methyl]-2-(2,3-dihydro-1,1 -dioxido-1,4-benzothiazepin-4(5 h)-yl)-6-methyl-4-quinazolinamine for the treatment of respiratory syncytial virus (rsv) infections |
| CA3002494C (en) | 2015-11-12 | 2021-01-12 | F. Hoffmann-La Roche Ag | Compositions for treating spinal muscular atrophy |
| CN108697709A (zh) | 2015-12-10 | 2018-10-23 | Ptc医疗公司 | 用于治疗亨廷顿病的方法 |
| EP3386978B1 (en) | 2015-12-10 | 2021-01-27 | H. Hoffnabb-La Roche Ag | Bridged piperidine derivatives |
| FR3061494B1 (fr) | 2016-12-29 | 2020-07-03 | Arkema France | Procede de synthese de dithiocarbamates cycliques fonctionnalises |
| WO2018226622A1 (en) | 2017-06-05 | 2018-12-13 | Ptc Therapeutics, Inc. | Compounds for treating huntington's disease |
| EP3645121B8 (en) | 2017-06-28 | 2025-06-18 | PTC Therapeutics, Inc. | Methods for treating huntington's disease |
| BR112019027717A2 (pt) | 2017-06-28 | 2020-07-28 | Ptc Therapeutics, Inc. | métodos para tratar a doença de huntington |
| CA3094703A1 (en) | 2018-03-27 | 2019-10-03 | Ptc Therapeutics, Inc. | Compounds for treating huntington's disease |
| JP7421507B2 (ja) | 2018-06-27 | 2024-01-24 | ピーティーシー セラピューティクス， インコーポレイテッド | ハンチントン病を処置するためのヘテロ環式およびヘテロアリール化合物 |
| CN112805280B (zh) | 2018-06-27 | 2024-12-06 | Ptc医疗公司 | 用于治疗亨廷顿氏病的杂芳基化合物 |
| WO2020005882A1 (en) | 2018-06-27 | 2020-01-02 | Ptc Therapeutics, Inc. | Heteroaryl compounds for treating huntington's disease |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2945859A (en) * | 1960-07-19 | Diaminoquinazolines and method of | ||
| BE501634A (cg-RX-API-DMAC7.html) * | 1950-03-02 | |||
| US3155572A (en) * | 1959-04-13 | 1964-11-03 | Merck & Co Inc | Compositions and methods for treating coccidiosis |
| GB1062357A (en) * | 1965-03-23 | 1967-03-22 | Pfizer & Co C | Quinazolone derivatives |
| GB1131126A (en) * | 1966-03-10 | 1968-10-23 | Pfizer Ltd | 2-vinyl-1,4-dihydroquinazoline derivatives |
| US3511836A (en) * | 1967-12-13 | 1970-05-12 | Pfizer & Co C | 2,4,6,7-tetra substituted quinazolines |
| US3637701A (en) * | 1969-03-03 | 1972-01-25 | Sandoz Ag | Certain nitrate derivatives of 4-aminoquinazolines |
| US3635979A (en) * | 1969-09-29 | 1972-01-18 | Pfizer | Certain 6- and/or 7-alkoxy-substituted-2 4-bis(disubstituted amino) quinazolines |
| US3669968A (en) * | 1970-05-21 | 1972-06-13 | Pfizer | Trialkoxy quinazolines |
-
1972
- 1972-09-09 GB GB4199272A patent/GB1383409A/en not_active Expired
-
1973
- 1973-08-20 ZA ZA735660A patent/ZA735660B/xx unknown
- 1973-08-21 IN IN1920/CAL/73A patent/IN139088B/en unknown
- 1973-08-30 DK DK478273*A patent/DK131725C/da active
- 1973-08-31 CA CA180,089A patent/CA995673A/en not_active Expired
- 1973-09-03 IE IE1560/73A patent/IE38318B1/xx unknown
- 1973-09-03 AR AR249880A patent/AR203373A1/es active
- 1973-09-04 JP JP48098934A patent/JPS4985078A/ja active Pending
- 1973-09-05 US US05/394,491 patent/US3960861A/en not_active Expired - Lifetime
- 1973-09-06 DE DE2366106A patent/DE2366106C2/de not_active Expired
- 1973-09-06 BE BE135402A patent/BE804558A/xx unknown
- 1973-09-06 DE DE2345064A patent/DE2345064C3/de not_active Expired
- 1973-09-06 AT AT774573A patent/AT330785B/de active
- 1973-09-07 LU LU68373A patent/LU68373A1/xx unknown
- 1973-09-07 NL NL7312350.A patent/NL161152C/xx not_active IP Right Cessation
- 1973-09-07 FR FR7332315A patent/FR2198751B1/fr not_active Expired
- 1973-09-08 ES ES418612A patent/ES418612A1/es not_active Expired
-
1975
- 1975-01-08 SU SU2095549A patent/SU555850A3/ru active
- 1975-07-11 IN IN1357/CAL/75A patent/IN141109B/en unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2296757C2 (ru) * | 2002-07-05 | 2007-04-10 | Ф.Хоффманн-Ля Рош Аг | Производные хиназолина |
| RU2664643C2 (ru) * | 2014-01-24 | 2018-08-21 | Ф. Хоффманн-Ля Рош Аг | Способ получения n-[(3-аминооксетан-3-ил)метил]-2-(1,1-диоксо-3,5-дигидро-1,4-бензотиазепин-4ил)-6-метил-хиназолин-4-амина |
Also Published As
| Publication number | Publication date |
|---|---|
| AU5960673A (en) | 1975-02-27 |
| IN141109B (cg-RX-API-DMAC7.html) | 1977-01-22 |
| DE2366106B1 (de) | 1979-06-21 |
| FR2198751A1 (cg-RX-API-DMAC7.html) | 1974-04-05 |
| IE38318B1 (en) | 1978-02-15 |
| CA995673A (en) | 1976-08-24 |
| US3960861A (en) | 1976-06-01 |
| DE2366106C2 (de) | 1980-02-14 |
| GB1383409A (en) | 1974-02-12 |
| LU68373A1 (cg-RX-API-DMAC7.html) | 1975-05-21 |
| AR203373A1 (es) | 1975-09-08 |
| ATA774573A (de) | 1975-10-15 |
| JPS4985078A (cg-RX-API-DMAC7.html) | 1974-08-15 |
| IN139088B (cg-RX-API-DMAC7.html) | 1976-05-08 |
| AT330785B (de) | 1976-07-26 |
| IE38318L (en) | 1974-03-09 |
| BE804558A (fr) | 1974-03-06 |
| DE2345064B2 (de) | 1979-03-08 |
| NL161152C (nl) | 1980-01-15 |
| FR2198751B1 (cg-RX-API-DMAC7.html) | 1977-01-28 |
| DK131725B (da) | 1975-08-25 |
| DE2345064C3 (de) | 1979-10-25 |
| DK131725C (da) | 1976-01-26 |
| NL7312350A (cg-RX-API-DMAC7.html) | 1974-03-12 |
| NL161152B (nl) | 1979-08-15 |
| ZA735660B (en) | 1974-07-31 |
| DE2345064A1 (de) | 1974-04-11 |
| ES418612A1 (es) | 1976-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SU555850A3 (ru) | Способ получени производных хиназолина | |
| Nesterova et al. | Synthesis and study the pharmacological activity of derivatives of 5-dimethylaminopyrano [3, 2-c] quinolin-2-ones | |
| NO179748B (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive bis-(1H-indol-3-yl)-maleinimidderivater | |
| GB1573809A (en) | Basically substituted indole derivative and process for their manufacture | |
| SU1609449A3 (ru) | Способ получени индентиазола | |
| ES382550A1 (es) | Procedimiento para la preparacion de nuevas 2-aminoalcohi- lamino-tieno (3,2-d) pirimidinas. | |
| ES439811A1 (es) | Procedimiento para la preparacion de derivados de bencimida-zol. | |
| Jones et al. | Vic-dicarboxylic acid derivatives of pyrazole, isoxazole, and pyrimidine | |
| Markgraf et al. | Strained heterocyclic systems. IV. 1, 2-Dihydrocyclobuta [b] quinoline and derivatives | |
| EP0591058A1 (fr) | Dérivés d'Ellipticine à activité antitumorale | |
| US3458515A (en) | Piperazine substituted pyrroles | |
| Adamson | 13. The anhydrides of basic amino-acids | |
| FI58118C (fi) | Foerfarande foer framstaellning av n-(1-etyl-alfa-pyrrolidylmetyl)-2-metoxi-5-sulfamidobensamid | |
| Glushkov et al. | Synthesis and antiinflammatory and analgesic activity of amidines of 3, 4-dihydroisoquinoline series | |
| US3072650A (en) | Amides of 2-(aminomethyl)-oxacycloalkanes | |
| SU432718A3 (ru) | Способ получения2-замещенных производных1-циннамилбензимидазола | |
| US5098919A (en) | Pyrrolo(2,1-b)thiazole derivatives | |
| FUJII et al. | Lactams. II. Synthesis and Acid Hydrolysis of 1-Benzyl-2-piperidone Derivatives Possessing the Carboxyl Function: Equilibrium between 6-and 5-Membered Lactams | |
| SU655307A3 (ru) | Способ получени производных гуанидинов или их солей | |
| US3647785A (en) | Novel 3-indolylaliphatic acid anhydrides | |
| NO133230B (cg-RX-API-DMAC7.html) | ||
| Saldabol et al. | Synthesis and transformations of furan derivatives: VI. Amides of β-(2-furyl)-and β-(5-nitro-2-furyl-α-acylamdoacrylic acids) and 1-substituted 2-phenyl-4-(5′ nitro-2′-furfuryliden)-5-imidazolones | |
| Zakhs et al. | Synthesis and properties of salts of 2-substituted derivatives of 1, 6-dimethyl-7-chloro-1, 6-diazaphenalenium salts, III | |
| ES413374A1 (es) | Procedimiento para preparar imidas de esteres de acidos n- (aminometiliden)-tiolfosforicos y tionofosforicos disusti- tuidos. | |
| Zhungietu et al. | Synthesis of 5H-pyridazo [4, 5-b] indoles by condensation of 2-acylindole-3-carboxylic acids with hydrazine |